12/11/2024  21:50:38 Chg. - Volume Bid22:00:00 Ask22:00:00 Market Capitalization Dividend Y. P/E Ratio
202.40EUR - 165
Turnover: 33,661.20
194.55Bid Size: 29 196.60Ask Size: 28 10 bill.EUR - -

Business description

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Its employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
 

Management board & Supervisory board

CEO
James C. Foster
Management board
Flavia Pease, William D. Barbo, Victoria L. Creamer, Birgit Girshick, Joseph W. LaPlume, Shannon M. Parisotto, Brian Bathgate, Ph.D., Matthew L. Daniel, Kerstin Dolph, Colin S. Dunn, Ph.D., Kristen M. Eisenhauer, Professor Julie Frearson, Ph.D., Wilbert Frieling, D.V.M., E.R.T., John C. Ho, M.D., Foster T. Jordan, Michael G. Knell, Mark Mintz, Gina M. Mullane, Barbara J. Patterson
Supervisory board
James C. Foster, Nancy C. Andrews M.D., Ph.D., Robert J. Bertolini, Deborah T. Kochevar, D.V.M., Ph.D., D.A.C.V.C.P., George Llado, Martin Mackay, Ph.D., George E. Massaro, C. Richard Reese, Craig B. Thompson, M.D., Richard F. Wallman, Virginia M. (Gina) Wilson
 

Company data

Name: Charles River Laboratories International, Inc.
Address: 251 Ballardvale Street,Wilmington, Massachusetts 01887, USA
Phone: +1-781-222-6000
Fax: -
E-mail: -
Internet: www.criver.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 31/12
Free Float: 88.30%
IPO date: 23/06/2000

Investor relations

Name: -
IR phone: +1-781-222-6190
IR Fax: -
IR e-mail: askcharlesriver@crl.com